Unknown

Dataset Information

0

Ribonuclease 5 facilitates corneal endothelial wound healing via activation of PI3-kinase/Akt pathway.


ABSTRACT: To maintain corneal transparency, corneal endothelial cells (CECs) exert a pump function against aqueous inflow. However, human CECs are arrested in the G1-phase and non-proliferative in vivo. Thus, treatment of corneal endothelial decompensation is limited to corneal transplantation, and grafts are vulnerable to immune rejection. Here, we show that ribonuclease (RNase) 5 is more highly expressed in normal human CECs compared to decompensated tissues. Furthermore, RNase 5 up-regulated survival of CECs and accelerated corneal endothelial wound healing in an in vitro wound of human CECs and an in vivo cryo-damaged rabbit model. RNase 5 treatment rapidly induced accumulation of cytoplasmic RNase 5 into the nucleus, and activated PI3-kinase/Akt pathway in human CECs. Moreover, inhibition of nuclear translocation of RNase 5 using neomycin reversed RNase 5-induced Akt activation. As a potential strategy for proliferation enhancement, RNase 5 increased the population of 5-bromo-2'-deoxyuridine (BrdU)-incorporated proliferating CECs with concomitant PI3-kinase/Akt activation, especially in CECs deprived of contact-inhibition. Specifically, RNase 5 suppressed p27 and up-regulated cyclin D1, D3, and E by activating PI3-kinase/Akt in CECs to initiate cell cycle progression. Together, our data indicate that RNase 5 facilitates corneal endothelial wound healing, and identify RNase 5 as a novel target for therapeutic exploitation.

SUBMITTER: Kim KW 

PROVIDER: S-EPMC4985649 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ribonuclease 5 facilitates corneal endothelial wound healing via activation of PI3-kinase/Akt pathway.

Kim Kyoung Woo KW   Park Soo Hyun SH   Lee Soo Jin SJ   Kim Jae Chan JC  

Scientific reports 20160816


To maintain corneal transparency, corneal endothelial cells (CECs) exert a pump function against aqueous inflow. However, human CECs are arrested in the G1-phase and non-proliferative in vivo. Thus, treatment of corneal endothelial decompensation is limited to corneal transplantation, and grafts are vulnerable to immune rejection. Here, we show that ribonuclease (RNase) 5 is more highly expressed in normal human CECs compared to decompensated tissues. Furthermore, RNase 5 up-regulated survival o  ...[more]

Similar Datasets

| S-EPMC3968008 | biostudies-literature
| S-EPMC4795706 | biostudies-literature
| S-EPMC3022035 | biostudies-literature
| S-EPMC7425707 | biostudies-literature
| S-EPMC2923192 | biostudies-literature
| S-EPMC4589775 | biostudies-other
| S-EPMC6158251 | biostudies-literature
| S-EPMC3547945 | biostudies-literature
| S-EPMC8496719 | biostudies-literature
| S-EPMC6128418 | biostudies-literature